重慶農村商業銀行(03618.HK)董事及高管累計增持11.22萬股A股
格隆匯5月8日丨重慶農村商業銀行(03618.HK)發佈公告,截至2019年12月9日,在本行領取薪酬的非獨立董事、高級管理人員共12人(以下簡稱“增持主體”),通過上海證券交易所繫統集中競價交易方式,以不超過上一年度自本行領取薪酬(税後)15%的自有資金增持本行股份,增持實施期限為自2019年12月9日起6個月內。
本次增持計劃實施期間,增持主體以自有資金通過上海證券交易所繫統以集中競價方式累計增持本行A股股份11.22萬股,成交價格區間為每股人民幣6.57元至6.79元,合計增持金額75.70萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.